Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

SHBG binding properties are unchanged in male liver cirrhosis patients.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Male rats have androgen receptors in their liver, which are different from proteins that bind estrogen.

Blocking the FGF5 gene in sheep leads to more fine wool and active hair follicles due to changes in certain cell signaling pathways.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Topical estrogen helps hair growth in menopausal women with no major side effects.

Hormonal therapies help treat female hair loss, but results are slow and vary.